[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338591-105":59,"doc-detail-338591-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-potential-of-cellular-homing-behavior-in-tumor-immunotherapy-from-basic-discoveries-to-clinical-applications-of-immune-mesenchymal-stem-and-cancer-cell-homing","The potential of cellular homing behavior in tumor immunotherapy: from basic discoveries to clinical applications of immune, mesenchymal stem, and cancer cell homing","","Immunotherapy effectiveness depends on effector cells reaching and localizing at tumor sites, a capability tied to the homing behavior of specific cell types. This review explains how immune cells, mesenchymal stem cells, and cancer cells can be engineered or utilized for targeted anti-tumor therapy, while noting that cancer cell-homing based immunotherapy remains early in development. It emphasizes mechanisms to improve homing efficiency, overcome immune resistance in the tumor microenvironment, and address delivery challenges for in vivo therapeutic agents.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-potential-of-cellular-homing-behavior-in-tumor-immunotherapy-from-basic-discoveries-to-clinical-applications-of-immune-mesenchymal-stem-and-cancer-cell-homing/338591/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-potential-of-cellular-homing-behavior-in-tumor-immunotherapy-from-basic-discoveries-to-clinical-applications-of-immune-mesenchymal-stem-and-cancer-cell-homing/338591.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is cell homing important for tumor immunotherapy?","Question",{"text":112,"@type":113},"Immunotherapy efficacy relies on effector cells localizing at tumor sites. Their navigational ability is closely linked to the homing behaviors of specific cell types.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What roles do immune cells and mesenchymal stem cells play in targeted tumor therapy?",{"text":117,"@type":113},"Recent studies focus on leveraging immune cells and mesenchymal stem cells for targeted therapy through their homing capabilities to tumor-related sites.",{"name":119,"@type":110,"acceptedAnswer":120},"What challenges limit cancer cell homing–based immunotherapy today?",{"text":121,"@type":113},"Research in this area is still preliminary, and progress requires improving homing efficiency while addressing immune resistance within the tumor microenvironment and delivery challenges for in vivo therapeutic agents.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338591,1790380469,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","TYPE Review  \nPUBLISHED 12 December 2024 DOI 10.3389/fimmu.2024.1495978  \nOPEN ACCESS  \nEDITED BY  \nLuigi Cari,  \nUniversity of Perugia, Italy  \nREVIEWED BY  \nFatemeh Talebian,  \nThe Ohio State University, United States Tao Yang,  \nGuizhou University of Traditional Chinese Medicine, China  \n*CORRESPONDENCE  \nYanju Bao  \n [baoyjtx@163.com](baoyjtx@163.com)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \nRECEIVED 13 September 2024  \nACCEPTED 28 November 2024  \nPUBLISHED 12 December 2024  \nCITATION  \nLi D, Yang Y, Zheng G, Meng L, Shang L, Ren J, Wang L and Bao Y (2024) The potential of cellular homing behavior in tumor immunotherapy: from basic discoveries to clinical applications of immune, mesenchymal stem, and cancer cell homing.  \nFront. Immunol. 15:1495978 .  \ndoi: 10.3389/fimmu.2024.1495978  \nCOPYRIGHT  \n© 2024 Li, Yang, Zheng, Meng, Shang, Ren, Wang and Bao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe potential of cellular homing behavior in tumor immunotherapy: from basic discoveries to clinical applications of immune, mesenchymal stem, and cancer cell homing  \nDongtao Li 1†, Yixuan Yang 1†, Guangda Zheng 1, Linghan Meng 1, Lu Shang 2, Juanxia Ren 2, Lingyun Wang 2 and Yanju Bao 1*  \n1 Department of Oncology, Guang ’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China, 2 First Clinical College, Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China  \nThe efﬁcacy of immunotherapy, a pivotal approach in the arsenal of cancer treatment strategies, is contingent on the capacity of effector cells to localize atthe tumor site. The navigational capacity of these cells is intricately linked to the homing behaviors of speciﬁc cell types. Recent studies have focused on leveraging immune cells and mesenchymal stem cells (MSCs) homing for targeted tumor therapy and incorporating cancer cell homing properties into anti-tumor strategies. However, research and development of immunotherapy based on cancer cell homing remain in their preliminary stages. Enhancing the homing efﬁciency of effector cells is essential; therefore, understanding the underlying mechanisms and addressing immune resistance within the tumor microenvironment and challenges associated with in vivo therapeutic agent delivery are essential. This review ﬁrstly delineates the discovery and clinical translation of the three principal cell-homing behaviors. Secondly, we endeavor to conduct an in-depth analysis of existing research on the homing of immune and stem cells in cancer therapy, with the aim of identifying and understanding of the common applications, potential beneﬁts, barriers, and critical success factors of cellular homing therapies. Finally, based on the understanding of the key factors of cellular homing therapies, we provide an overview and outlook on the enormous potential of harnessing cancer cells ’ self-homing to treat tumors. Although immunotherapy based on cell-homing behavior warrants further research, it remains a highly competitive treatment modality that can be combined with existing classic anti-cancer therapies. In general, combining the homing properties of cells to optimize their clinical effects is also one of the future research directions in the ﬁeld of cell transplantation.  \nKEYWORDS  \nimmunotherapy, tumor, tumor microenvironment, cell homing, treatment strategies  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nCell homing, a critical cellular migration process, signiﬁcantly affects organismal development, tissue regener","cbCaidD2g3zi7JMk","https://ap.wps.com/l/cbCaidD2g3zi7JMk","pdf",3849387,12,"English","# Introduction\n## Cell homing: definition and historical context\n## Tumor biology and current cancer treatment approaches","[{\"question\":\"Why is cell homing important for tumor immunotherapy?\",\"answer\":\"Immunotherapy efficacy relies on effector cells localizing at tumor sites. Their navigational ability is closely linked to the homing behaviors of specific cell types.\"},{\"question\":\"What roles do immune cells and mesenchymal stem cells play in targeted tumor therapy?\",\"answer\":\"Recent studies focus on leveraging immune cells and mesenchymal stem cells for targeted therapy through their homing capabilities to tumor-related sites.\"},{\"question\":\"What challenges limit cancer cell homing–based immunotherapy today?\",\"answer\":\"Research in this area is still preliminary, and progress requires improving homing efficiency while addressing immune resistance within the tumor microenvironment and delivery challenges for in vivo therapeutic agents.\"}]","The potential of cellular homing behavior in tumor immunotherapy: from basic discoveries to clinical applications of immune, mesenchymal stem, and cancer cell homing | PDF",1790024380,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6cc1fd45255e705e2b9181aa2b00fb7a.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b54f346820f6ab4eeecbebedec27244.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30cbe3cdd72e2c624c1d7a27ba70a771.webp",981,1386,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/24f64312cd1bbee6cd7142987ffe8d09.webp",980,1385]